Intra-abdominal infections represent the second most frequently acquired infection in the intensive care unit, with mortality rates ranging from 20% to 50%.

Candida spp. may be responsible for up to 10–30% of cases.

Recurrent gastrointestinal perforation, anastomotic leakage and prior antibiotic therapy have been identified as risk factors for developing intra-abdominal candidiasis.

Prospective clinical studies are needed to identify which patients will benefit from early antifungal treatment.